Login
Home
Charts
Search
Watchlist
Products

Link Pharma Chem Ltd

LINKPH·BSE
27.00-4.76%Wed, 23 Sept '26 15:03

Link Pharma Chem Ltd

LINKPH
BSE
27.00
-4.76%
|Wed, 23 Sept '26 15:03
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
12Cr
Close
Close Price
27.00
Industry
Industry
Chemicals - Organic
PE
Price To Earnings
PS
Price To Sales
0.42
Revenue
Revenue
28Cr
Rev Gr TTM
Revenue Growth TTM
16.31%
PAT Gr TTM
PAT Growth TTM
100.00%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
688955686779
Growth YoY
Revenue Growth YoY%
-28.6-15.2-13.612.3-20.7-32.8-19.7-11.831.026.02.212.3
Expenses
ExpensesCr
787855776678
Operating Profit
Operating ProfitCr
-101100010100
OPM
OPM%
-14.73.511.56.2-6.32.1-3.48.25.410.3-3.55.1
Other Income
Other IncomeCr
00000-1000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
-10000-1010000
Tax
TaxCr
000000000000
PAT
PATCr
-10000-1000000
Growth YoY
PAT Growth YoY%
-206.322.2236.8136.669.6-404.6-234.633.3106.5110.5-17.1-20.0
NPM
NPM%
-16.92.83.23.4-6.5-12.6-5.45.10.31.0-6.23.6
EPS
EPS
-2.30.50.60.7-0.7-1.5-0.80.90.00.1-0.90.7
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
688955686779
Growth YoY
Revenue Growth YoY%
-28.6-15.2-13.612.3-20.7-32.8-19.7-11.831.026.02.212.3
Expenses
ExpensesCr
787855776678
Operating Profit
Operating ProfitCr
-101100010100
OPM
OPM%
-14.73.511.56.2-6.32.1-3.48.25.410.3-3.55.1
Other Income
Other IncomeCr
00000-1000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
-10000-1010000
Tax
TaxCr
000000000000
PAT
PATCr
-10000-1000000
Growth YoY
PAT Growth YoY%
-206.322.2236.8136.669.6-404.6-234.633.3106.5110.5-17.1-20.0
NPM
NPM%
-16.92.83.23.4-6.5-12.6-5.45.10.31.0-6.23.6
EPS
EPS
-2.30.50.60.7-0.7-1.5-0.80.90.00.1-0.90.7

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
121624252535543930252728
Growth
Revenue Growth%
-29.830.446.24.14.036.753.9-27.6-22.9-14.97.916.3
Expenses
ExpensesCr
131421222332503631252627
Operating Profit
Operating ProfitCr
02323343-1011
OPM
OPM%
-1.312.511.88.210.28.56.67.0-2.20.55.34.4
Other Income
Other IncomeCr
300000001000
Interest Expense
Interest ExpenseCr
111000011111
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
10111231-2-100
Tax
TaxCr
00000110-1000
PAT
PATCr
10111121-1-100
Growth
PAT Growth%
127.0-61.7400.9-42.044.314.273.4-65.2-308.324.6107.5100.0
NPM
NPM%
4.81.44.82.73.73.13.51.7-4.6-4.00.30.0
EPS
EPS
1.30.52.61.52.12.44.21.5-3.1-2.30.20.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
121624252535543930252728
Growth
Revenue Growth%
-29.830.446.24.14.036.753.9-27.6-22.9-14.97.916.3
Expenses
ExpensesCr
131421222332503631252627
Operating Profit
Operating ProfitCr
02323343-1011
OPM
OPM%
-1.312.511.88.210.28.56.67.0-2.20.55.34.4
Other Income
Other IncomeCr
300000001000
Interest Expense
Interest ExpenseCr
111000011111
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
10111231-2-100
Tax
TaxCr
00000110-1000
PAT
PATCr
10111121-1-100
Growth
PAT Growth%
127.0-61.7400.9-42.044.314.273.4-65.2-308.324.6107.5100.0
NPM
NPM%
4.81.44.82.73.73.13.51.7-4.6-4.00.30.0
EPS
EPS
1.30.52.61.52.12.44.21.5-3.1-2.30.20.0

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
44444444444
Reserves
ReservesCr
5456781011988
Current Liabilities
Current LiabilitiesCr
7745391115111011
Non Current Liabilities
Non Current LiabilitiesCr
22334443111
Total Liabilities
Total LiabilitiesCr
1817171819262932262325
Current Assets
Current AssetsCr
77779151418121111
Non Current Assets
Non Current AssetsCr
1110111110111515141214
Total Assets
Total AssetsCr
1817171819262932262325
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
44444444444
Reserves
ReservesCr
5456781011988
Current Liabilities
Current LiabilitiesCr
7745391115111011
Non Current Liabilities
Non Current LiabilitiesCr
22334443111
Total Liabilities
Total LiabilitiesCr
1817171819262932262325
Current Assets
Current AssetsCr
77779151418121111
Non Current Assets
Non Current AssetsCr
1110111110111515141214
Total Assets
Total AssetsCr
1817171819262932262325

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-424135-1-2032
Investing Cash Flow
Investing Cash FlowCr
9-1-1-1-2-2-5002-3
Financing Cash Flow
Financing Cash FlowCr
-6-1-3010220-41
Net Cash Flow
Net Cash FlowCr
-100022-40000
Free Cash Flow
Free Cash FlowCr
513013-2-3-120
CFO To PAT
CFO To PAT%
-659.9984.4333.8207.1311.0446.6-66.9-260.92.0-261.42,791.3
CFO To EBITDA
CFO To EBITDA%
2,447.7110.4136.467.6113.6163.0-35.6-62.84.32,075.7148.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-424135-1-2032
Investing Cash Flow
Investing Cash FlowCr
9-1-1-1-2-2-5002-3
Financing Cash Flow
Financing Cash FlowCr
-6-1-3010220-41
Net Cash Flow
Net Cash FlowCr
-100022-40000
Free Cash Flow
Free Cash FlowCr
513013-2-3-120
CFO To PAT
CFO To PAT%
-659.9984.4333.8207.1311.0446.6-66.9-260.92.0-261.42,791.3
CFO To EBITDA
CFO To EBITDA%
2,447.7110.4136.467.6113.6163.0-35.6-62.84.32,075.7148.9

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
561211811181619151012
Price To Earnings
Price To Earnings
8.625.810.816.88.09.79.524.9133.3
Price To Sales
Price To Sales
0.40.40.50.50.30.30.30.40.60.60.40.4
Price To Book
Price To Book
0.60.71.31.10.70.81.21.11.41.20.80.9
EV To EBITDA
EV To EBITDA
-61.85.05.26.63.33.16.69.1-42.8160.211.615.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
33.744.539.634.038.630.521.127.923.929.738.438.4
OPM
OPM%
-1.312.511.88.210.28.56.67.0-2.20.55.34.4
NPM
NPM%
4.81.44.82.73.73.13.51.7-4.6-4.00.30.0
ROCE
ROCE%
11.79.816.310.312.313.114.76.9-4.5-3.43.33.3
ROE
ROE%
6.62.611.66.38.38.613.04.3-9.9-8.10.60.6
ROA
ROA%
3.31.36.63.75.04.26.52.0-5.3-4.40.30.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
561211811181619151012
Price To Earnings
Price To Earnings
8.625.810.816.88.09.79.524.9133.3
Price To Sales
Price To Sales
0.40.40.50.50.30.30.30.40.60.60.40.4
Price To Book
Price To Book
0.60.71.31.10.70.81.21.11.41.20.80.9
EV To EBITDA
EV To EBITDA
-61.85.05.26.63.33.16.69.1-42.8160.211.615.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
33.744.539.634.038.630.521.127.923.929.738.438.4
OPM
OPM%
-1.312.511.88.210.28.56.67.0-2.20.55.34.4
NPM
NPM%
4.81.44.82.73.73.13.51.7-4.6-4.00.30.0
ROCE
ROCE%
11.79.816.310.312.313.114.76.9-4.5-3.43.33.3
ROE
ROE%
6.62.611.66.38.38.613.04.3-9.9-8.10.60.6
ROA
ROA%
3.31.36.63.75.04.26.52.0-5.3-4.40.30.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Link Pharma Chem Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/hw0mw8t9nby6gi0668pp1xzu.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/9bbpwszz5zppvwa7hkv1rgvi.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/shzwn3h15xe5sfutqjm7krl0.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/4nzt9xju3ja7eckd0m3odcyw.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/n5r1se1ot7ei92mz5kq2obgo.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/3jaoft9xh2dmbwh26qh0rya7.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/w11xwxwx9t526vxdwj9272qj.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/jbaisqptntsgmxfqffx733yq.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/982zfbaw0uyg76iqj2qsyrrd.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/rh7vx0vz3isyqwowges3ikok.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/ge74qbbtuag9h9w6r8zzyjqo.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/pb7gxkbc4fgz2ub55x0c4hxk.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/kh6fjtturuqqm4by2pv4t8z5.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/t2lboyprzt0z34pxrbrrgy2s.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/yrv855lkbfie86yu419tmqdv.pdf